MYGN

SEC source: 0001843872-24-000004 · wk-form4_1728592265.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,582

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2024.

SEC source: 0001517026-24-000004 · wk-form4_1727122860.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 297,640

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 20, 2024.

SEC source: 0001843568-24-000006 · wk-form4_1727122641.xml · nonDerivative · entry 1

Ancona Margaret · CIK 0001843568 · SVP, Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,400

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 20, 2024.

SEC source: 0001932320-24-000008 · wk-form4_1727122519.xml · nonDerivative · entry 1

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,259

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 20, 2024.

SEC source: 0001628280-24-040232 · wk-form4_1726171896.xml · nonDerivative · entry 1

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 977,378

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001922964-24-000006 · wk-form4_1726171753.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,013

SEC source: 0001379372-24-000002 · wk-form4_1725918488.xml · nonDerivative · entry 1

Dreismann Heinrich · CIK 0001379372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,648

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.02 to $27.13, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001914879-24-000007 · wk-form4_1725487665.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,771

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-24-039405 · wk-form4_1725487777.xml · nonDerivative · entry 1

Reitan Colleen F · CIK 0001740730 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,533

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.45 to $28.47, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001932320-24-000006 · wk-form4_1724705280.xml · nonDerivative · entry 1

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,223

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 23, 2024.

SEC source: 0001843568-24-000004 · wk-form4_1724444186.xml · nonDerivative · entry 1

Ancona Margaret · CIK 0001843568 · SVP, Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,366

SEC source: 0001824720-24-000003 · wk-form4_1724186279.xml · nonDerivative · entry 1

Kumar Rashmi · CIK 0001824720 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 77,392

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001628280-24-037225 · wk-form4_1723667218.xml · nonDerivative · entry 2

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 992,378

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 13, 2024.

SEC source: 0001628280-24-037225 · wk-form4_1723667218.xml · nonDerivative · entry 1

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,043,358

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 13, 2024.

SEC source: 0001628280-24-027334 · wk-form4_1717793673.xml · nonDerivative · entry 1

Dreismann Heinrich · CIK 0001379372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,648

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-24-027333 · wk-form4_1717793661.xml · nonDerivative · entry 1

Newcomer Lee Nisley · CIK 0001788981 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,345

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-24-027332 · wk-form4_1717793649.xml · nonDerivative · entry 1

Kumar Rashmi · CIK 0001824720 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,892

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-24-027331 · wk-form4_1717793637.xml · nonDerivative · entry 1

Reitan Colleen F · CIK 0001740730 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,545

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-24-027329 · wk-form4_1717793624.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,648

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-24-027328 · wk-form4_1717793613.xml · nonDerivative · entry 1

BISARO PAUL · CIK 0001237253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,145

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-24-027520 · wk-form4_1718050526.xml · nonDerivative · entry 1

Skovronsky Daniel · CIK 0001741474 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,010

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001238403-24-000002 · wk-form4_1717538237.xml · nonDerivative · entry 2

SPIEGELMAN DANIEL K · CIK 0001238403 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,917

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001238403-24-000002 · wk-form4_1717538237.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,705

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001628280-24-023653 · wk-form4_1715809753.xml · nonDerivative · entry 3

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,066,166

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.64 to $25.60, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001628280-24-023653 · wk-form4_1715809753.xml · nonDerivative · entry 2

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,141,166

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.915 to $25.49, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001628280-24-023653 · wk-form4_1715809753.xml · nonDerivative · entry 1

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,236,166

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.83, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001788981-24-000002 · wk-form4_1715809662.xml · nonDerivative · entry 1

Newcomer Lee Nisley · CIK 0001788981 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,650

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.30 to $25.39, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001922964-24-000004 · wk-form4_1713212823.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,113

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 12, 2024.

SEC source: 0001517026-24-000002 · wk-form4_1713212713.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 298,715

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 12, 2024.

SEC source: 0001932320-24-000004 · wk-form4_1712609373.xml · nonDerivative · entry 1

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,440

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 5, 2024.

SEC source: 0001932320-24-000002 · wk-form4_1711570651.xml · nonDerivative · entry 1

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,021

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 25, 2024.

SEC source: 0001628280-24-012919 · wk-form4_1711398717.xml · nonDerivative · entry 3

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,384

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012919 · wk-form4_1711398717.xml · nonDerivative · entry 2

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,964

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012917 · wk-form4_1711398681.xml · nonDerivative · entry 3

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,097

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012917 · wk-form4_1711398681.xml · nonDerivative · entry 2

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,815

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012916 · wk-form4_1711398666.xml · nonDerivative · entry 3

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,053

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012916 · wk-form4_1711398666.xml · nonDerivative · entry 2

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,614

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012915 · wk-form4_1711398651.xml · nonDerivative · entry 3

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299,791

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012915 · wk-form4_1711398651.xml · nonDerivative · entry 2

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 301,375

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012914 · wk-form4_1711398639.xml · nonDerivative · entry 3

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,294,010

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012914 · wk-form4_1711398639.xml · nonDerivative · entry 2

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,321,243

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012920 · wk-form4_1711398729.xml · nonDerivative · entry 1

Wong Pamela · CIK 0001885862 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,002

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012919 · wk-form4_1711398717.xml · nonDerivative · entry 1

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,365

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012918 · wk-form4_1711398698.xml · nonDerivative · entry 1

Ancona Margaret · CIK 0001843568 · SVP, Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,904

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012917 · wk-form4_1711398681.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,987

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012916 · wk-form4_1711398666.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,996

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012915 · wk-form4_1711398651.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,036

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-012914 · wk-form4_1711398639.xml · nonDerivative · entry 1

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,339,832

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC source: 0001628280-24-011688 · wk-form4_1710794786.xml · nonDerivative · entry 1

Wong Pamela · CIK 0001885862 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,443

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 15, 2024.

SEC source: 0001628280-24-011686 · wk-form4_1710794750.xml · nonDerivative · entry 2

Ancona Margaret · CIK 0001843568 · SVP, Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,634

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 15, 2024.